Sansure Biotech Inc. (SHA:688289)
18.41
+0.07 (0.38%)
Mar 9, 2026, 3:00 PM CST
Sansure Biotech Revenue
In the year 2025, Sansure Biotech had annual revenue of 1.65B CNY with 13.04% growth. Sansure Biotech had revenue of 404.11M in the quarter ending December 31, 2025, a decrease of -5.02%.
Revenue
1.65B
Revenue Growth
+13.04%
P/S Ratio
6.41
Revenue / Employee
702.58K
Employees
2,409
Market Cap
10.57B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tinavi Medical Technologies | 283.26M |
| Eyebright Medical Technology (Beijing) | 1.48B |
| Tofflon Science and Technology Group | 5.22B |
| Aidite (Qinhuangdao) Technology | 993.58M |
| Autek China | 1.82B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.19B |
| Jiangsu Hualan New Pharmaceutical Material | 604.86M |
| Hubei Huaqiang High-Tech | 628.32M |